The spatial distribution of T-lymphocytes has been shown to be an important prognostic indicator in some cancers, including CRC, particularly in the Immunocore assay based on quantification of CD3+ and CD8+ T-lymhocytes densities [6,22,23]. This evidence concerns the gene CD8A and cancer.